An infection that occurs at or near a surgical incision site, either superficially on the skin or deep within the tissues, within 30 days after surgery or up to one year in the case of implanted materials.
Procedures and practices employed in the operating room to maintain a sterile environment, minimizing the risk of introducing microorganisms and preventing surgical site infections.
Substances, such as iodine or chlorhexidine, applied to the skin or mucous membranes to inhibit the growth of microorganisms and reduce the risk of surgical site infections.
Antibiotics administered before surgery to prevent infections, typically targeting bacteria commonly found in the surgical site, and administered within a specific time frame for maximum effectiveness.
An SSI that extends beyond the skin and subcutaneous tissues, affecting muscles, fascia, or other deeper structures surrounding the surgical site.
An SSI limited to the skin and subcutaneous tissues at the surgical incision site, typically presenting with redness, swelling, and discharge.
The partial or complete separation of the layers of a surgical wound, which may increase the risk of contamination and contribute to the development of surgical site infections.
A thin, slimy layer of microorganisms that adheres to surfaces, including surgical implants, and can serve as a reservoir for bacteria, contributing to the persistence of surgical site infections.
The flushing or cleansing of a surgical wound with a sterile solution to remove debris, bacteria, and contaminants, reducing the risk of infection.
The ongoing monitoring, care, and management of patients after surgery to prevent complications, including the development of surgical site infections.